Signals of progress
Ibogaine news
Momentum is building. These are the developments we consider genuinely encouraging for Boston, New England and the wider United States — funding decisions, legislative progress and peer-reviewed results. Every item links to its original source so you can read it in full and judge it yourself.
Boston & New England
· Psychedelic Alpha
Harvard awarded an $11M NIDA grant for ibogaine research in opioid use disorder
The National Institute on Drug Abuse funded a multi-phase ibogaine project at Harvard — the clearest sign yet that this work is moving into mainstream federally funded science in the Boston area.
· The Boston Globe
Boston Globe opinion: psychedelic therapy could save veterans' lives
The founders of Veterans Exploring Treatment Solutions argue the moment for psychedelic medicine has arrived, citing the 2024 Stanford results in veterans.
· GBH News
GBH: ibogaine is gaining ground in the treatment of addiction and PTSD
Boston public radio covers the federal executive order aimed at accelerating review and research of psychedelics, with ibogaine specifically highlighted.
· South Shore Senior News
Beacon Hill hears veterans and clinicians on psychedelic therapy
Testimony from veterans and medical experts preceded committee votes on H.4200 and H.2203, signalling growing legislative momentum in Massachusetts.
· Boston Institute for Nonprofit Journalism
Massachusetts lawmakers advance psychedelic therapy bills covering ibogaine
Two bills advanced out of the Joint Committee on Mental Health, Substance Use and Recovery, raising the prospect of a state programme for ibogaine and psilocybin.
· Boston magazine
Boston magazine: what's the deal with ibogaine?
A local primer on the promise and the perils of ibogaine, published as Massachusetts voters weighed the Question 4 psychedelics ballot measure.
United States
· The Texas Tribune
Texas moves to run its own ibogaine clinical trials
After no drug company stepped forward, the state committed to running the trials itself — keeping the largest public ibogaine research programme in the country on track.
· The Texas Tribune
Texas approves $50 million for ibogaine clinical trials
Lawmakers funded trials of ibogaine for addiction and brain trauma, the largest state investment in psychedelic research in the country to date.
Research
A note on balance
Encouraging headlines do not remove the risks. Strictly for informational and research purposes. Not medical advice. Ibogaine carries serious cardiac risk and requires qualified medical screening and continuous supervision.
Send an enquiry